Romiplostim

1 study on Romiplostim curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

Bottom line: TitrateLab currently curates 1 dated study on Romiplostim. The source summaries below describe published research; they do not establish product quality, safety, or clinical suitability.

Romiplostim studies and clinical research

2026-04-17 PubMed · preclinical animal · n preclinical

Thrombopoietin Receptor Agonists Show Promise for Non-Muscle Myosin Heavy Chain 9-Related Disease

This research provides compelling preclinical evidence that thrombopoietin receptor agonists could offer a targeted and effective therapeutic strategy for MYH9-RD, a rare disease with significant unmet medical needs. …

Research tools

Free, no account — handy when you're working with Romiplostim.

Reconstitution calculator Bac water, concentration & insulin-unit math Verify a COA Look up a report number against our corpus

TitrateLab PRO

Unlock the complete evidence trail

Pro members save studies and unlock the full evidence breakdown and vendor lab data.

Complete vendor lab histories
Every linked certificate on file
Batch-level purity and quantity detail
Thousands of community reviews

Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.

$12 monthly or $33 lifetime

Create free account

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.

Romiplostim studies and clinical research

Thrombopoietin Receptor Agonists Show Promise for Non-Muscle Myosin Heavy Chain 9-Related Disease

Research tools